跳到主要內容

Rothblatt Martine A 的 Form 4 申報

United Therapeutics Corp(UTHR),2026/8/17 申報

申報編號
0001106578-26-000121
申報時間
2026/8/17 16:34 ET
交易日
2026/8/14
申報延遲
3 天
10b5-1 計畫
有勾選

這份申報列了 8 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $474.0 萬。交易後 3 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Rothblatt Martine ACIK 0001106578董事、高階主管(董事長、執行長)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2026/8/14Common StockM行使選擇權取得+9,500$135.42+$1,286,490333,943間接
2026/8/14Common StockS賣出處分−320$495.02F3−$158,407.42333,623間接
2026/8/14Common StockS賣出處分−414$495.96F4−$205,329.43333,209間接
2026/8/14Common StockS賣出處分−537$497.22F5−$267,006.71332,672間接
2026/8/14Common StockS賣出處分−2,130$498.39F6−$1,061,579.65330,542間接
2026/8/14Common StockS賣出處分−3,630$499.30F7−$1,812,445.57326,912間接
2026/8/14Common StockS賣出處分−2,148$500.05F8−$1,074,098.59324,764間接
2026/8/14Common StockS賣出處分−321$500.93F9−$160,796.93324,443間接

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2026/8/14Common StockM行使選擇權處分−9,500$0.00$0132,410間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F3

This transaction was executed in multiple trades at prices ranging from $494.61 to $495.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 1 筆交易的價格引用這則附註。

F4

This transaction was executed in multiple trades at prices ranging from $495.65 to $496.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 1 筆交易的價格引用這則附註。

F5

This transaction was executed in multiple trades at prices ranging from $496.71 to $497.69. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 1 筆交易的價格引用這則附註。

F6

This transaction was executed in multiple trades at prices ranging from $497.72 to $498.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 1 筆交易的價格引用這則附註。

F7

This transaction was executed in multiple trades at prices ranging from $498.73 to $499.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 1 筆交易的價格引用這則附註。

F8

This transaction was executed in multiple trades at prices ranging from $499.73 to $500.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 1 筆交易的價格引用這則附註。

F9

This transaction was executed in multiple trades at prices ranging from $500.82 to $501.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)